HARRIGAN EDMUND — SEC Form 4 filings
SEC reporting owner CIK 1177917. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-04-02 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INCYTE CORP (INCY) | Director | 13 | — | — | 16 |
| ACADIA PHARMACEUTICALS INC (ACAD) | Director | 3 | — | — | 12 |
Form 4 filings — HARRIGAN EDMUND
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 255 @ $113.36 | EDGAR |
| 2026-06-10 | 4 | INCYTE CORP (INCY) | Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 8,107 · Option exercise (M): 8,107 (derivative) @ $0 · Grant/award (A): 16,004 (derivative) @ $0 · Grant/award (A): 9,311 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 269 @ $94.12 | EDGAR |
| 2026-01-05 | 4 | INCYTE CORP (INCY) | Grant/award (A): 245 @ $98.77 | EDGAR |
| 2025-10-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 289 @ $84.81 | EDGAR |
| 2025-07-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 367 @ $68.10 | EDGAR |
| 2025-06-12 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 9,387 · Option exercise (M): 9,387 (derivative) @ $0 · Grant/award (A): 13,793 (derivative) @ $0 · Grant/award (A): 8,107 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 363 @ $60.55 | EDGAR |
| 2025-01-03 | 4 | INCYTE CORP (INCY) | Grant/award (A): 339 @ $69.07 | EDGAR |
| 2024-10-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 378 @ $66.10 | EDGAR |
| 2024-07-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 409 @ $60.62 | EDGAR |
| 2024-06-14 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,830 @ $0 · Grant/award (A): 12,517 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,652 · Option exercise (M): 6,652 (derivative) @ $0 · Grant/award (A): 15,959 (derivative) @ $0 · Grant/award (A): 9,387 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 413 @ $56.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1177917 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →